<p>The growing use of reduced-dose radiotherapy in patients with primary cutaneous lymphoma is a&#xa0;promising development. Nevertheless, the absence of controlled clinical trials to ascertain standardized doses for each specific type constitutes a&#xa0;significant impediment to the advancement of this field. This expert opinion strongly advocates for advancements in radiation oncology practice that address the unique complexities of primary cutaneous lymphoma. By refining our methodologies, we can optimize patient care and outcomes in this dynamic field.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group

  • Khaled Elsayad,
  • Dora Correia,
  • Ulrike Theiß,
  • Andrea Baehr,
  • Angela Besserer,
  • Oliver Micke,
  • Burkhard Greve,
  • Cora Waldstein,
  • Stefanie Corradini,
  • Daniel Habermehl,
  • Laila König,
  • Kathrin Hering,
  • Sebastian Adeberg,
  • Hans Theodor Eich

摘要

The growing use of reduced-dose radiotherapy in patients with primary cutaneous lymphoma is a promising development. Nevertheless, the absence of controlled clinical trials to ascertain standardized doses for each specific type constitutes a significant impediment to the advancement of this field. This expert opinion strongly advocates for advancements in radiation oncology practice that address the unique complexities of primary cutaneous lymphoma. By refining our methodologies, we can optimize patient care and outcomes in this dynamic field.